Verition Fund Management
BPMC

Verition Fund Management’s Blueprint Medicines BPMC Stock Holding History

Verition Fund Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-118,988
Closed -$15.3M – 3766
2025
Q2 		$15.3M Buy
118,988
+101,775
+591% +$10.6M 0.07% 331
2025
Q1 		$1.52M Sell
17,213
-17,861
-51% -$1.74M 0.01% 1774
2024
Q4 		$3.06M Buy
35,074
+25,315
+259% +$2.32M 0.01% 1256
2024
Q3 		$903K Buy
9,759
+4,260
+77% +$423K ﹤0.01% 1955
2024
Q2 		$593K Buy
5,499
+3,034
+123% +$304K ﹤0.01% 1964
2024
Q1 		$234K Buy
+2,465
New +$211K ﹤0.01% 2426
2021
Q3 		– Sell
-2,966
Closed -$261K – 1927
2021
Q2 		$261K Buy
+2,966
New +$272K ﹤0.01% 1418
2020
Q3 		– Sell
-12,620
Closed -$984K – 1070
2020
Q2 		$984K Buy
+12,620
New +$854K 0.03% 420

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Verition Fund Management's BPMC Position: Q3 2025 in Review

Verition Fund Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 118,988 shares — an estimated $15.3M sold.

Verition Fund Management first reported a position in BPMC in Q2 2020 and held it in 8 quarters. The position peaked at $15.3M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Verition Fund Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 118,988 Blueprint Medicines shares in Q3 2025, an estimated $15.3M.
  • Verition Fund Management first reported a position in Blueprint Medicines in Q2 2020 and held it in 8 quarters.
  • Verition Fund Management's Blueprint Medicines position peaked at $15.3M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.